Navigation Links
Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
Date:7/22/2013

Ticker=IMMY"> IMMY) is a specialty pharmaceutical company focused on the commercial development of compounded drug formulations. Through its exclusive strategic relationship with Professional Compounding Centers of America (PCCA), the largest compounding pharmacy organization in North America, Imprimis expects to use its proprietary Accudel drug delivery technologies, as well as proprietary drug formulations for new indications and market data obtained through PCCA, to identify and pursue pharmaceutical development opportunities where there is a significant unmet medical need utilizing the FDA 505(b)(2) regulatory pathway. Imprimis' most near term drug candidate, Impracor, is a Phase III product candidate that utilizes the Accudel topical cream formulation to deliver the active drug ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its localized anti-inflammatory and analgesic effects. For more information, visit http://imprimispharma.com/

About Agility Clinical, Inc.

Agility Clinical, Inc. was founded in 2012 with an experienced executive management team whose mission is to help small and virtual pre-clinical and clinical stage companies develop drugs and devices, particularly in the orphan drug category.  In addition to consulting, Agility provides customized full clinical trial services including project management, clinical operations, data management, biostatistics, medical, regulatory, and scientific affairs, medical writing and electronic source records (ESR).  The Agility team has a true appreciation for the challenges virtual companies face in obtaining the expertise they need.  Agility has established operations in Carlsbad, CA.  For more information, please visit www.agility-clinical.c
'/>"/>

SOURCE Imprimis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
2. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
3. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
4. Imprimis Names Two Experts To Its Science And Regulatory Board
5. Imprimis to Begin New Study of Its Topical Analgesic Drug
6. Imprimis Pharmaceuticals Announces Pricing of Public Offering of 1,840,000 Shares of Common Stock
7. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
8. Imprimis Announces Key Leadership Appointments
9. Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to resolutionMD for Cosmeceutical Products
10. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
11. Imprimis Pharmaceuticals, Inc. to Present at the National Investment Banking Association (NIBA) Conference June 18th in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... EASTON, Mass. , Sept. 19, 2014 /PRNewswire/ ... "Company") today announced it has received and approved ... Barozyme HT48 instruments and has begun to manufacture ... the first instrument will be ready for shipment ... be built and released at a rate of ...
(Date:9/19/2014)... and ORLANDO, Fla. , ... supporting Inspire therapy continues to grow, with the publication ... published on-line in Otolaryngology – Head and ... causes a worsening of both objective and subjective measures ... directly attribute Inspire therapy for the reduction in obstructive ...
(Date:9/19/2014)... -- Intarcia Therapeutics, Inc. today announced the ... candidate ITCA 650 (continuous subcutaneous delivery of exenatide) in ... at the 50 th Annual Meeting of the ... from the open-label, phase 3 FREEDOM-HBL (high baseline) trial ... with poorly controlled type 2 diabetes. The results were ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
(Date:9/20/2014)... Mexico (PRWEB) September 20, 2014 The ... including Villa del Palmar Cabo San Lucas, Villa La ... relation to Hurricane Odile, with plans to welcome guests ... , As of Sept. 19, all members and guests ... home, thanks to a coordinated effort with government authorities. ...
(Date:9/20/2014)... 2014 Ticket Down is a ... This popular ticket exchange is offering their customer appreciation ... nearing that next step in the entertainment business. The 21-year-old ... the music and entertainment business, but is closing in on ... No. 1 album, will hit the road next year on ...
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog post explaining the ... provides for vulnerable family members. , Providing financial ... priority for every provider. It is now possible to ... visiting a doctor. , Life insurance plans that ... to $300,000, but only to healthy applicants. Clients who ...
(Date:9/20/2014)... New York, NY (PRWEB) September 20, 2014 ... Ariana Grande concert tickets for her 2015 “Honeymoon ... appreciation promo code ARIANA-2015 for added savings. , In early ... the biggest stars in the world across North America. Twenty-one-year-old ... the “Honeymoon Tour,” which will take her to 25 cities ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA ... its new website. The new site provides the ... products for customers. Here, people can find a ... decision. Also, it has recommended some excellent web ... of the great web hosting suppliers, InMotion ( ...
Breaking Medicine News(10 mins):Health News:Villa Group Resorts in Cabo Largely Unharmed, Plan to Re-open Early October 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 2Health News:Ariana Grande Tickets in Chicago/Rosemont, Kansas City, Milwaukee, Saint Paul, Dallas, Houston, San Antonio, Oklahoma City Go On Sale Today 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2
... less health conscious and may be spending less time daily ... that working full time leads to a sedentary life style ... work full time have less time for leisure, which is ... in front of the computer. These seem to be the ...
... Clopidogrel and aspirin is more effective than only aspirin//., ... four countries of the Europe were given the combination ... the study had had a stroke or transient ischemic ... narrower carotid arteries. The experimental group had microscopic blood ...
... say cholesterol may be actually needed to help insulate the ... that too much of it could end up in // ... up as plaque and can cause heart attacks and strokes. ... blame for the build-up. ACAT2 is one of four enzymes ...
... way the final fetal head position is going to be.//, ... and delivery. This is a form of painkiller that is ... pelvic muscles and nerves get the anesthetic medication. The lady ... longer be in pain. ,A study was conducted ...
... of menopausal symptoms. However if this is used in// conjunction ... be altered. ,Scientists of Yale School of Medicine in ... medication taken by breast cancer patients may alter the way ... not even aware of the fact that their patients may ...
... starts on its immunity system to fight the infection.// ... infections are fought by the human immunity system. A ... of Medicine had identified a molecule that triggers the ... caused by the parasite. ,A parasite called Toxoplasma ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: